Skip to main content
. 2023 Jul 18;10:1188971. doi: 10.3389/fmed.2023.1188971

Table 3.

Distribution of SARC-F scores of NDD-CKD and MHD patients.

NDD-CKD
SARC-F, frequency (%)
MHD
SARC-F, frequency (%)
Nonsarcopenia (n = 99) Sarcopenia (n = 6) Nonsarcopenia (n = 86) Sarcopenia (n = 39)
Strength
No difficulty 94 (94.9) 1 (16.7) 60 (69.8) 11 (28.2)
Some difficulty 5 (5.1) 5 (83.3) 18 (20.9) 16 (41.0)
Extreme difficulty or inability 0 (0) 0 (0) 8 (9.3) 12 (30.8)
Assistance in walking
No difficulty 98 (99.0) 5 (83.3) 76 (88.4) 27 (69.2)
Some difficulty 1 (1.0) 1 (16.7) 5 (5.8) 11 (28.2)
Extreme difficulty or inability 0 (0) 0 (0) 5 (5.8) 1 (2.6)
Rising from a chair
No difficulty 98 (99.0) 4 (66.7) 69 (80.2) 20 (51.3)
Some difficulty 1 (1.0) 1 (16.7) 13 (15.1) 14 (35.9)
Extreme difficulty or inability 0 (0) 1 (16.7) 4 (4.7) 5 (12.8)
Climbing stairs
No difficulty 97 (98.0) 2 (33.3) 63 (73.3) 15 (38.4)
Some difficulty 2 (2.0) 3 (50.0) 17 (19.8) 12 (30.8)
Extreme difficulty or inability 0 (0) 1 (16.7) 6 (6.9) 12 (30.8)
Falls
None 98 (99.0) 5 (83.3) 78 (90.7) 35 (89.7)
1–3 1 (1.0) 1 (16.7) 8 (9.3) 3 (7.7)
≥4 0 (0) 0 (0) 0 (0) 1 (2.6)

CKD-NDD, chronic kidney disease with nondialysis dependence; MHD, maintenance hemodialysis.